A device for the manufacture and administration of a smart therapeutic composition for the treatment of diabetes and Alzheimer's
disease, the device comprising the following: an extraction chamber configured to isolate phytochemicals derived from turmeric, including curcuminoids and turmerones, from turmeric
rhizome powder or pre-purified extracts, the extraction chamber further comprising a
solvent-assisted ultrasonic unit and a temperature-controlled housing to maintain bioactive stability during extraction; a microfluidic encapsulation chamber which is operatively connected to the extraction chamber and is configured to embed the extracted phytochemicals in lipid-
polymer hybrid nanoparticles, wherein the encapsulation chamber comprises a
polydimethylsiloxane (PDMS) microchannel network, flow-controlled carrier inlets and a photonic scattering sensor to monitor the size distribution of the nanoparticles; a stabilization unit located downstream of the encapsulation chamber and configured to convert the encapsulated nanoparticles into stable formulations by means of freeze-
drying or spray-
drying, wherein the stabilization unit includes a
humidity-controlled environment to maintain long-term storage stability; a delivery interface configured to deliver the stabilized formulations via oral capsules or transdermal patches, the delivery interface also including a
microprocessor-operated dosage controller for programmable delivery schedules; a
biosensor array integrated into the device, configured to detect biomarkers from the group consisting of glucose, indicators of
oxidative stress, and β-
amyloid fragments; and a
feedback control system that is operationally connected to the
biosensor array and the microfluidic encapsulation chamber, wherein the
feedback control system includes an embedded
microcontroller with adaptive techniques to dynamically adjust encapsulation ratios,
nanoparticle size and dosing intervals based on patient-specific biomarker data.